Radiopaedia Helpers

List Punctuation

error

"¹⁸⁸Re-HDD (4-hexadecyl-4,7-diaza-1,10-decanedithiol)] lipiodol is widely used but unfortunately, the labelling yield with ¹⁸⁸Re-HDD lipiodol is poor; chelating agent N-DEDC (nitrido-diethyl-dithicarbamato) is cheaper, easier to tag and more stable ¹³, and the final lipophilic complex, bis-(diethyldithiocarbamato) nitrido rhenium-188, to be administered through the hepatic artery, is labelled Re-188 N (DEDC) 2-Lipiodol^3-6."

Line 32:479 · Do not put full stops at the end of a list item.

Acronyms

warning

"Lipiodol (also known as ethiodized oil) is an oil-based iodinated contrast medium that was historically used for myelography and hysterosalpingography ¹. Newer, less hazardous agents later superseded it and are now used primarily as therapeutic agents. Guerbet was previously the sole manufacturer of this agent. Vivere Imaging has also formulated a similar agent named Vividol, which has obtained FDA approval."

Line 1:485 · 'FDA' has no definition. Spell it out if it's unfamiliar to the audience.

"¹⁸⁸Re-HDD (4-hexadecyl-4,7-diaza-1,10-decanedithiol)] lipiodol is widely used but unfortunately, the labelling yield with ¹⁸⁸Re-HDD lipiodol is poor; chelating agent N-DEDC (nitrido-diethyl-dithicarbamato) is cheaper, easier to tag and more stable ¹³, and the final lipophilic complex, bis-(diethyldithiocarbamato) nitrido rhenium-188, to be administered through the hepatic artery, is labelled Re-188 N (DEDC) 2-Lipiodol^3-6."

Line 32:25 · 'HDD' has no definition. Spell it out if it's unfamiliar to the audience.

"¹⁸⁸Re-HDD (4-hexadecyl-4,7-diaza-1,10-decanedithiol)] lipiodol is widely used but unfortunately, the labelling yield with ¹⁸⁸Re-HDD lipiodol is poor; chelating agent N-DEDC (nitrido-diethyl-dithicarbamato) is cheaper, easier to tag and more stable ¹³, and the final lipophilic complex, bis-(diethyldithiocarbamato) nitrido rhenium-188, to be administered through the hepatic artery, is labelled Re-188 N (DEDC) 2-Lipiodol^3-6."

Line 32:158 · 'HDD' has no definition. Spell it out if it's unfamiliar to the audience.

"It was previously marketed as Ethiodol in the US but is now globally sold as Lipiodol. Vividol, developed in India, and being made available globally is emerging as a biosimilar alternative."

Line 50:50 · 'US' has no definition. Spell it out if it's unfamiliar to the audience.

List Caps

warning

"Lipiodol has been tagged with radioisotopes for locoregional therapy of primary and secondary liver tumours"

Line 16:8 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Re188-Lipiodol"

Line 26:4 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Re is rhenium, a transition metal ¹⁴"

Line 30:12 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

Headings Valid

warning

Expected headings

H1 Terminology
H1 Usage
H1 Epidemiology
H2 Risk factors
H2 Associations
H1 Clinical presentation
H2 Complications
H1 Diagnosis
H2 Diagnostic criteria
H2 Diagnostic clues
H1 Pathology
H2 Aetiology
H2 Location
H2 Classification
H2 Macroscopic appearance
H2 Microscopic appearance
H2 Immunophenotype
H2 Markers
H2 Genetics
H1 Radiographic features
H2 Plain radiograph
H2 Mammography
H2 Antenatal ultrasound
H2 Transoesophageal echocardiography
H2 Ultrasound
H2 CT
H3 Dual-energy CT
H2 Angiography (DSA)
H2 MRI
H2 CT/MRI
H2 Nuclear medicine
H3 PET-CT
H3 PET-MRI
H1 Radiology report
H1 Treatment and prognosis
H2 Complications
H1 History and etymology
H1 Differential diagnosis
H2 Clinical differential diagnosis
H1 Practical points
H1 See also

"Structure"

Line 2:1 · "Structure" is not a recognised heading for this article type.

"Uses"

Line 4:1 · "Uses" is not a recognised heading for this article type.

"Diagnostic"

Line 5:1 · "Diagnostic" is not a recognised heading for this article type.

"Therapeutic"

Line 11:1 · "Therapeutic" is not a recognised heading for this article type.

Parentheses

suggestion

"¹⁸⁸Re-HDD (4-hexadecyl-4,7-diaza-1,10-decanedithiol)] lipiodol is widely used but unfortunately, the labelling yield with ¹⁸⁸Re-HDD lipiodol is poor; chelating agent N-DEDC (nitrido-diethyl-dithicarbamato) is cheaper, easier to tag and more stable ¹³, and the final lipophilic complex, bis-(diethyldithiocarbamato) nitrido rhenium-188, to be administered through the hepatic artery, is labelled Re-188 N (DEDC) 2-Lipiodol^3-6."

Line 32:29 · Use parentheses judiciously. There are at least 3 sets in this paragraph.

Commas

suggestion

"¹⁸⁸Re-HDD (4-hexadecyl-4,7-diaza-1,10-decanedithiol)] lipiodol is widely used but unfortunately, the labelling yield with ¹⁸⁸Re-HDD lipiodol is poor; chelating agent N-DEDC (nitrido-diethyl-dithicarbamato) is cheaper, easier to tag and more stable ¹³, and the final lipophilic complex, bis-(diethyldithiocarbamato) nitrido rhenium-188, to be administered through the hepatic artery, is labelled Re-188 N (DEDC) 2-Lipiodol^3-6."

Line 32:43 · More than 5 commas in a single sentence might make it more difficult to read.

Semicolons

suggestion

"¹⁸⁸Re-HDD (4-hexadecyl-4,7-diaza-1,10-decanedithiol)] lipiodol is widely used but unfortunately, the labelling yield with ¹⁸⁸Re-HDD lipiodol is poor; chelating agent N-DEDC (nitrido-diethyl-dithicarbamato) is cheaper, easier to tag and more stable ¹³, and the final lipophilic complex, bis-(diethyldithiocarbamato) nitrido rhenium-188, to be administered through the hepatic artery, is labelled Re-188 N (DEDC) 2-Lipiodol^3-6."

Line 32:178 · Use semicolons judiciously.

Biographical Lifespan

suggestion

"History and etymology"

Line 47:1 · A bold element in the History and etymology section should be a person; it would be useful to have their lifespan details: '<h4>History and etymology</h4> <p>Lipiodol was discovered by the co-founders of the healthcare company Guerbet, <strong>Marcel Guerbet</strong> '

Lint: lipiodol